A randomized control trial to assess optical coherence tomography parameters of the Xlimus drug-eluting stent: the XLIMIT trial.
Frontiers in cardiovascular medicine（2023）
摘要
ClinicalTrials.gov, identifier (NCT03745053).
更多查看译文
关键词
third generation DES, neointimal volume, OCT, restenosis, endothelialization third generation DES
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要